Pharmaceutical Technology on MSN

THX Pharma and Biocodex sign licensing deal for Batten-1 and TX01 drugs

THX Pharma is set to receive total payments up to $206.1m.

THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases

THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance the development of two drug ...
PharmaTimes

Thx Pharma and Biocodex sign rare disease licensing deal

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...
PharmiWeb

THX Pharma and Biocodex Forge Strategic Rare Disease Licensing Agreement

THX Pharma and Biocodex strike a strategic €173 million licensing deal to advance Batten-1 and TX01 for three rare diseases with high unmet need, combining development and commercial expertise to bene ...
PMLive

THX Pharma appoints Julien Veys as Deputy CEO

Theranexus (THX) Pharma has announced the appointment of Julien Veys as Deputy CEO.
iGyaan Network

THX Sues Apple Over Speaker Patent

Apple Inc. has been accused by THX Ltd., a company founded by “Star Wars” producer George Lucas, of stealing speaker technology used in iPhones, iPads and iMac products. According to the complaint, ...
ecoustics

KEF Introduces New THX-Certified In-Wall Speakers: Ci3120QLM-THX and Ci5120QLM-THX Deliver Reference-Grade Home Theater Sound

KEF expands its Extreme Home Theater line with the THX-Certified Ci5120QLM-THX and Ci3120QLM-THX in-wall speakers, priced at $1,699.99 and $1,299.99 each. The high-end in-wall speaker market has ...